Raising Awareness of Uterine Fibroids: A Patient-Centered Approach to Optimize Outcomes in Rural and Underserved Settings

Released On
February 28, 2022

Expires On
February 28, 2023

Media Type

Completion Time
60 minutes

Obstetrics & Gynecology, Primary Care

Bleeding Disorders, Pain

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Postgraduate Institute for Medicine and RME Collaborative.


This online program is recorded content from the live session at the 3rd Annual Rural Health Clinical Congress and co-supported by independent medical education grants from AbbVie, Inc.; AstraZeneca Pharmaceuticals; Eisai, Inc.; Genentech, a member of the Roche Group; Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.; Novartis Pharmaceutical Corporation; and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is supported by an independent medical education grant from AbbVie, Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit
  • Physicians — 1.0 ABIM MOC Point
  • Nurses — 1.0 Contact Hour (0.25 contact hour of pharmacotherapy credit)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.

Program Overview

Uterine fibroids are common, non-malignant tumors of the uterus that occur in up to 70% of women of reproductive age. While most cases are asymptomatic, approximately 25% of impacted individuals experience clinical symptoms that are severe enough to require treatment and negatively impact quality of life. Women in rural and underserved communities, particularly Black women, are disproportionately impacted and are more likely to experience severe symptoms and post-surgical complications. This CME/CE activity will review best practices for assessment and diagnosis of uterine fibroids as well as current and emerging treatments for the condition. Strategies for overcoming barriers to management of uterine fibroids in rural and underserved communities will also be addressed.

This enduring activity is a recorded session from the 3rd Annual Rural Health Clinical Congress that took place on November 20, 2021.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Recognize the signs and symptoms of uterine fibroids to improve timely diagnosis
  • Integrate an individualized approach for treatment of uterine fibroids based on current evidence, symptoms, and patient preferences
  • Utilize strategies for improving care for patients with uterine fibroids in rural and underserved areas



Hugh S. Taylor, MD

Anita O'Keeffe Young Professor of Obstetrics, Gynecology, and Reproductive Sciences
Professor of Molecular, Cellular, and Developmental Biology
Chair of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine
Chief of Obstetrics and Gynecology, Yale-New Haven Hospital
New Haven, CT


Barbara P. Yawn, MD, MSc, FAAFP (Moderator)

Professor of Family and Community Health
University of Minnesota
Minneapolis, MN

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

Credit Designation

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For physicians claiming ABIM MOC points, your information will be shared through the ACCME’s Program and Activity Reporting System (PARS). Please allow approximately 30 days for your MOC points to appear on your ABIM records.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.25 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine and RME Collaborative adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Postgraduate Institute for Medicine requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies (commercial interests). All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to Postgraduate Institute for Medicine policy. Postgraduate Institute for Medicine is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


Hugh S. Taylor, MD, has no relevant financial relationships to disclose.

Barbara P. Yawn, MD, MSc, FAAFP, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer

The Postgraduate Institute for Medicine and RME Collaborative planners, managers, and reviewer have nothing to disclose.

Instructions for Participation and Credit

This activity is offered at no cost to participants. To receive CME credit participants must:

  1. Read the CME/CE information, including learning objectives and disclosure statements.
  2. Complete the pre-test.
  3. View the online activity.
  4. Complete the post-test and evaluation form.

A post-test score of 66% or higher is required to obtain credit. Your certificate will be made available for immediate download.

For Physicians Claiming ABIM MOC Credit
To obtain MOC credit, you must provide your ABIM number and DOB (MM/DD) in the activity evaluation form.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

©RME Collaborative, a division of Talem Health, LLC 2022. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.


Internet activity

Fee Information

There is no fee for this educational activity.

Contact Information

General Questions
For general information or questions about this activity, please contact RME Collaborative at 800-913-9370 or cme@cmeruralhealth.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine at inquiries@pimed.com.